X0508 4 2025-09-05 0001524566 WEALTHFRONT CORP WLTH 0002082642 Imberman Alan C/O WEALTHFRONT CORPORATION 261 HAMILTON AVENUE PALO ALTO CA 94301 false true false false CFO and Treasurer 0 Common Stock 2025-09-05 4 M 0 40000 2.45 A 79411 D Common Stock 2025-12-11 4 M 0 95785 0 A 175196 D Common Stock 2025-12-11 4 M 0 159687 0 A 334883 D Common Stock 2025-12-11 4 M 0 70875 0 A 405758 D Common Stock 2025-12-11 4 F 0 118893 14 D 286865 D Common Stock 2025-12-11 4 S 0 100000 14 D 186865 D Stock Option (Right to Buy) 2.45 2025-09-05 4 M 0 40000 0 D 2025-11-10 Common Stock 40000 0 D Restricted Stock Units 2025-10-13 4 A 0 284200 0 A Common Stock 284200 284200 D Restricted Stock Units 2025-12-11 4 M 0 95785 0 D Common Stock 95785 0 D Restricted Stock Units 2025-12-11 4 M 0 159687 0 D Common Stock 159687 205313 D Restricted Stock Units 2025-12-11 4 M 0 70875 0 D Common Stock 70875 307125 D The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer. The transaction represents the number of shares of Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of restricted stock units. The reported sale transaction represents the reporting person's participation in the Issuer's secondary offering, which occurred in conjunction with the IPO. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on October 26, 2019. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering, as well as a service-based vesting schedule. The award shall vest as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on March 15, 2026. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2024. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2025. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. /s/ Lauren Lin, as Attorney-in-Fact 2025-12-15